Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: Protocol of a prospective …
J Hua, W Zhang, H Cao, C Du, J Ma, Y Zuo, J Zhang - BMJ open, 2020 - bmjopen.bmj.com
Introduction Acute exacerbation (AE) is a major cause of disease progression and death in
patients with chronic obstructive pulmonary disease (COPD), accounting for majority of
medical expenditures. Correct inhalation therapy is effective in preventing AE attacks.
However, inappropriate usage of dry powder inhaler, partially due to the unrecovered peak
inhalation flow rate (PIFR) after acute exacerbation of COPD (AECOPD), results in increased
risk of early treatment failure. Therefore, we designed a multicentre, randomised clinical trial …
patients with chronic obstructive pulmonary disease (COPD), accounting for majority of
medical expenditures. Correct inhalation therapy is effective in preventing AE attacks.
However, inappropriate usage of dry powder inhaler, partially due to the unrecovered peak
inhalation flow rate (PIFR) after acute exacerbation of COPD (AECOPD), results in increased
risk of early treatment failure. Therefore, we designed a multicentre, randomised clinical trial …
[HTML][HTML] Protocol: Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol …
J Hua, W Zhang, H Cao, C Du, J Ma, Y Zuo, J Zhang - BMJ Open, 2020 - ncbi.nlm.nih.gov
Introduction Acute exacerbation (AE) is a major cause of disease progression and death in
patients with chronic obstructive pulmonary disease (COPD), accounting for majority of
medical expenditures. Correct inhalation therapy is effective in preventing AE attacks.
However, inappropriate usage of dry powder inhaler, partially due to the unrecovered peak
inhalation flow rate (PIFR) after acute exacerbation of COPD (AECOPD), results in increased
risk of early treatment failure. Therefore, we designed a multicentre, randomised clinical trial …
patients with chronic obstructive pulmonary disease (COPD), accounting for majority of
medical expenditures. Correct inhalation therapy is effective in preventing AE attacks.
However, inappropriate usage of dry powder inhaler, partially due to the unrecovered peak
inhalation flow rate (PIFR) after acute exacerbation of COPD (AECOPD), results in increased
risk of early treatment failure. Therefore, we designed a multicentre, randomised clinical trial …
以上显示的是最相近的搜索结果。 查看全部搜索结果